Xencor | Kundefordringer



Trade Debtors Endring Dato
AbbVie USD 10.92B 553M 2024-12
Alnylam Pharmaceuticals USD 405.31M 51.46M 2024-12
Amgen USD 6.78B 535M 2024-12
Arrowhead Research USD 2.5M 2.5M 2024-12
AstraZeneca USD 14.83B 1.28B 2024-12
Biogen USD 1.87B 119.3M 2024-12
Bristol-Myers Squibb USD 14.42B 471M 2024-12
Cytokinetics USD 16.65M 16.41M 2024-12
GlaxoSmithKline GBP 7.32B 542M 2024-12
J&J USD 14.84B 1.33B 2024-12
MacroGenics USD 8.75M 2.56M 2024-09
Merck USD 11.12B 1.06B 2024-12
Novartis USD 9B 854M 2024-12
Pfizer USD 14.78B 2.92B 2024-12
Regeneron Pharmaceuticals USD 6.21B 6B 2024-12
Roche Holding CHF 13.46B 984M 2024-12
Xencor USD 60.85M 50.64M 2024-12



Xencor Kundefordringer - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.